
Henning Hoelder
Henning Hoelder is a financial analyst known for his insights into the pharmaceutical industry. His commentary often focuses on market trends and the financial implications of mergers and acquisitions within the sector. Recently, he has been involved in discussions regarding a potential merger between AstraZeneca and Bristol Myers Squibb, which could reshape the landscape of the pharmaceutical market.
Power624
Reach7,714
Country presence
Recent news mentions
Henning Hoelder reported on the potential merger between AstraZeneca and BMS.
Gerüchte um Megafusion zwischen AstraZeneca und BMS irritieren den MarktNeue Zürcher Zeitung·
Switzerland· 2026-08-03







